Event Information

Share this event

Date and Time

Location

Location

Ian Potter Auditorium

Melbourne Brain Centre, Kenneth Myer Building

144/30 Royal Parade

Parkville, VIC 3052

Australia

View Map

Event description

Description

Gene therapy for glaucoma

presented by

Professor Keith Martin
Managing Director of Centre for Eye Research Australia and
Ringland Anderson Professor of Ophthalmology at the University of Melbourne


Please join us on Wednesday 18th September to hear from Professor Keith Martin who will deliver the 2019 David Danks Oration on the potential use of gene therapy to treat glaucoma.


Gene therapy promises to revolutionise the treatment of inherited eye disease. To date, this treatment has only been applied to rare diseases caused by single gene defects. Glaucoma is the leading cause of irreversible blindness worldwide, but only a small minority of glaucoma cases have single gene defects.


Glaucoma progression can often be slowed or stopped by lowering eye pressure, yet around 14% of glaucoma patients continue to go blind despite currently available treatments.


In this lecture, Professor Martin will explore the potential use of gene therapy to treat glaucoma that is progressing despite effective treatment to lower the eye pressure. In particular, Professor Martin will consider the use of a novel vector he has developed that modulates brain-derived neurotrophic factor signalling and is currently progressing towards human clinical trials.


I look forward to seeing you there.


Kind regards


Professor John Prins
Head, Melbourne Medical School


Date and Time

Location

Ian Potter Auditorium

Melbourne Brain Centre, Kenneth Myer Building

144/30 Royal Parade

Parkville, VIC 3052

Australia

View Map

Save This Event

Event Saved